Babies should get recently approved drug for RSV, CDC says

Indonesia Berita Berita

Babies should get recently approved drug for RSV, CDC says
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 AP
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

Infants should get a recently approved drug to protect them against a respiratory virus that affects tens of thousands of U.S. children each year, the CDC said.

Infants should get a recently approved drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, U.S. health officials said Thursday.

An infection with RSV is a coldlike nuisance for most healthy people, but it can be life-threatening for the very young and the elderly. There are no vaccines for babies yet so the, a lab-made antibody that helps the immune system fight off the virus, is expected to fill a critical need. The drug, developed by AstraZeneca and Sanofi, is expected to be ready in the fall before the RSV season, typically November through March. In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die.

A panel of outside advisers to the Centers for Disease Control and Prevention recommended the one-time shot for infants born just before or during the RSV season and for those less than 8 months old before the season starts. They also recommended a dose for some 8- to 19-months-olds at higher risk of a serious illness from RSV.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

AP /  🏆 728. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

CDC advisers vote to recommend new preventive RSV shot for all infants | CNNCDC advisers vote to recommend new preventive RSV shot for all infants | CNNAll infants under 8 months of age should get a new antibody shot to protect against hospitalization with respiratory syncytial virus, or RSV, according to a panel of independent experts that advises the United States Centers for Disease Control and Prevention on its immunization recommendations.
Baca lebih lajut »

New RSV shot for infants approved by CDCNew RSV shot for infants approved by CDCThe CDC signed off Thursday on a new RSV shot, made up of monoclonal antibodies that mimic the antibodies the body naturally creates when fighting a virus, for infants.
Baca lebih lajut »

CDC advisors recommend recently approved RSV shot for all infantsCDC advisors recommend recently approved RSV shot for all infantsAn infection with RSV is a coldlike nuisance for most healthy people, but it can be life-threatening for the very young and the elderly
Baca lebih lajut »

Babies should get new drug that prevents RSV, CDC panel saysBabies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, heath advisers recommended Thursday.
Baca lebih lajut »

Babies should get new drug that prevents RSV, CDC panel saysBabies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, health advisers recommended Thursday.
Baca lebih lajut »



Render Time: 2025-03-07 04:32:00